Key result
Depression is an independent risk factor for the development of type 2 diabetes and its complications, and its successful treatment may improve glycemic control and cardiovascular risk.
This review highlights the prognostic significance of depression in diabetes, emphasizing that treating depression may improve glycemic control and reduce cardiovascular risk.
Should not yet change diabetes care; hypothesis-generating for integrated depression treatment on cardiovascular outcomes.
The possibility of depression causing diabetes was first advanced in 1684 by Thomas Willis, who wrote that diabetes was the result of “sadness, or long sorrow.” Over the years, this view enjoyed little popular support, and depression more often was seen as something that occurred secondary to diabetes—a natural reaction to the arduous nature of the medical illness and its complications. In most cases, this view proved to be oversimplified or plainly mistaken. Studies dating the onsets of depression and diabetes in type 2 diabetes showed a distinct temporal relationship, wherein depression preceded diabetes in 90% of cases by 8–10 years. Subsequent longitudinal studies (reviewed in the previous articles) confirmed the prognostic significance of depression by showing that it is an independent risk factor both for the development of type 2 diabetes and for the development of complications of type 1 or type 2 diabetes, particularly coronary heart disease. The mechanisms by which depression imposes these risks have not been clearly established. The list of candidate mediators is long and varied, reflecting multifaceted effects of depression on behavioral and physiological factors that may interact with one another or change over time (Table 1). View this table: Table 1. Mediators of Depression Effects on Diabetes Course Identification of depression mechanisms that are relevant to medical outcome is the focus of much current research. And while the mechanisms involved remain to be clarified, the story outlined in the preceding sections has evolved sufficiently to suggest that potential benefits of depression treatment likely surpass expected improvements in mood and quality of life. Successful treatment of depression also may improve glycemic control, insulin effectiveness, and other measures of diabetes and cardiovascular risk and thereby enhance and prolong life. Realizing these possibilities requires that caregivers possess knowledge of mental and physical health and have the clinical skills and commitment …
No takes yet. Share an insight, caveat, or question.
Lustman et al. (2004) conducted a review in Depression and Diabetes. Depression was evaluated. Depression is an independent risk factor for the development of type 2 diabetes and its complications, and its successful treatment may improve glycemic control and cardiovascular risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: